Accession Number:

ADA341602

Title:

TITLE: Breast Tumor Immunity in the Paraneoplastic Neurologic Disorders.

Descriptive Note:

Annual rept. 1 Oct 96-30 Sep 97,

Corporate Author:

ROCKEFELLER UNIV NEW YORK

Personal Author(s):

Report Date:

1997-10-01

Pagination or Media Count:

12.0

Abstract:

Paraneoplastic neurologic disease PND antigens are proteins normally expressed specifically in neurons that are expressed ectopically in tumors. It is believed that when expressed in tumors outside of the immunologically privileged nervous system, PND antigens stimulate the development of anti-tumor immunity, but also stimulate an autoimmune neuronal degeneration. We are studying PNDs associated with breast cancer and immunity to the Nova and cdr2 antigens, assaying PND expression in clinical breast tumor specimens, and establishing animal models for the disorders. A prerequisite to studying the abnormal expression of PND antigens is an understanding of their normal expression. We have found that the Nova gene and antigen is normally restricted in expression to neurons. Strikingly, we have discovered that the cdr2 gene is widely expressed, but that its niRNA is under tight translational control, so that the cdr2 antigen is normally made only in neurons and immune privileged testes. This observation provides a novel insight to the biology of breast tumors, suggesting that they may dysregulate translational control to express abnormal proteins, and alters our approach to the analysis of cdr2 expression in vivo. We have also made significant progress in generating gene constructs to generate mouse models of PND.

Subject Categories:

  • Biology
  • Medicine and Medical Research

Distribution Statement:

APPROVED FOR PUBLIC RELEASE